SOMAXON PHARMACEUTICALS, INC. Selling, General and Administrative Expense
SOMAXON PHARMACEUTICALS, INC. reported Selling, General and Administrative Expense of $4.38 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-09-30 was $4.38M, a 75.82% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-06-30 was $5.30M, a 73.60% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-03-31 was $4.60M, a 75.26% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2011-12-31 was $12.99M, a 22.22% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2011 was $69.76M, a 90.71% increase from fiscal 2010.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2010 was $36.58M, a 236.39% increase from fiscal 2009.
- SOMAXON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2009 was $10.87M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $4.38M 10-Q · filed 2012-11-01 | $9.68M derived: sum of 2 quarters · filed 2012-11-01 | $14.28M 10-Q · filed 2012-11-01 | $27.27M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-06-30 | $5.30M 10-Q · filed 2012-08-08 | $9.90M 10-Q · filed 2012-08-08 | $22.89M derived: sum of 3 quarters · filed 2012-08-08 | $40.99M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-03-31 | $4.60M 10-Q · filed 2012-05-10 | $17.59M derived: sum of 2 quarters · filed 2012-05-10 | $35.69M derived: sum of 3 quarters · filed 2012-11-01 | $55.77M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $31.09M derived: sum of 2 quarters · filed 2012-11-01 | $51.16M derived: sum of 3 quarters · filed 2012-11-01 | $69.76M 10-K · filed 2012-03-09 |
| 2011-09-30 | $18.10M 10-Q · filed 2012-11-01 | $38.17M derived: sum of 2 quarters · filed 2012-11-01 | $56.77M 10-Q · filed 2012-11-01 | $73.47M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | $20.07M 10-Q · filed 2012-08-08 | $38.67M 10-Q · filed 2012-08-08 | $55.37M derived: sum of 3 quarters · filed 2012-08-08 | $67.29M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | $18.59M 10-Q · filed 2012-05-10 | $35.30M derived: sum of 2 quarters · filed 2012-05-10 | $47.22M derived: sum of 3 quarters · filed 2012-05-10 | $52.12M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $28.63M derived: sum of 2 quarters · filed 2012-03-09 | $33.53M derived: sum of 3 quarters · filed 2012-03-09 | $36.58M 10-K · filed 2012-03-09 |
| 2010-09-30 | $11.92M 10-Q · filed 2011-11-04 | $16.82M derived: sum of 2 quarters · filed 2011-11-04 | $19.88M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $4.90M 10-Q · filed 2011-08-03 | $7.95M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | $10.87M 10-K · filed 2012-03-09 |